The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Obesity and hyperlipidemia are risk factors for early diabetic neuropathy
Open accessAbstract
The Utah Diabetic Neuropathy Study (UDNS) examined 218 type 2 diabetic subjects without neuropathy symptoms, or with symptoms of < 5 years, in order to evaluate risk factors for neuropathy development. Each subject completed symptom questionnaires, the Utah Early Neuropathy Scale (UENS), nerve conduction studies (NCS), quantitative sensory testing (QST) for vibration and cold detection, quantitative sudomotor axon reflex testing (QSART), and skin biopsy with measurement of intraepidermal nerve fiber density (IENFD). Those with abnormalities of ≥ 3 were classified as having probable, and those with 1–2 as possible neuropathy. The relationship between glycemic control, lipid parameters (high density lipoprotein and triglyceride levels), blood pressure, and obesity, and neuropathy risk was examined. There was a significant relationship between the number of abnormalities among these features and neuropathy status (p<0.01). Hypertriglyceridemia, obesity and 3 or more abnormalities increased neuropathy risk (risk ratios 2.1 p<0.03, 2.9 p>0.02 and 3.0 p<0.004 respectively). Multivariate analysis found obesity and triglycerides were related to loss of small unmyelinated axons based on IENFD whereas elevated hemoglobin A1c was related to large myelinated fiber loss (motor conduction velocity). These findings indicate obesity and hypertriglyceridemia significantly increase risk for peripheral neuropathy, independent of glucose control. Obesity/hypertriglyceridemia and hyperglycemia may have differential effects on small versus large fibers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Basevi, V., Di Mario, S., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,055
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1303 · Cited by 2,690
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,293
Lauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Self-citationThe Health Care Costs of Diabetic Peripheral Neuropathy in the U.S.
Gordois, A., Scuffham, P., Shearer, A., Oglesby, A., & Tobian, J. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1790 · Cited by 734
Enhanced glucose control for preventing and treating diabetic neuropathy
Callaghan, B. C., Little, A. A., Feldman, E. L., & Hughes, R. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007543.pub2 · Cited by 584
Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study
Lauria, G., Bakkers, M., Schmitz, C., Lombardi, R., Penza, P., Devigili, G., Smith, A. G., Hsieh, S., Mellgren, S. I., Umapathi, T., et al. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00271.x · Cited by 518
Self-citationAlbers, J. W., Herman, W. H., Pop-Busui, R., Feldman, E. L., Martin, C. L., Cleary, P. A., Waberski, B. H., Lachin, J. M., & for the DCCT/EDIC Research Group (2010) · Diabetes Care · doi:10.2337/dc09-1941 · Cited by 401
Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy
Wiggin, T. D., Sullivan, K. A., Pop-Busui, R., Amato, A., Sima, A. A. F., & Feldman, E. L. (2009) · Diabetes · doi:10.2337/db08-1771 · Cited by 344
DCCT Research Group, B. N. (1995) · Annals of Neurology · doi:10.1002/ana.410380607 · Cited by 283
High-Fat Diet–Induced Neuropathy of Pre-Diabetes and Obesity
Obrosova, I. G., Ilnytska, O., Lyzogubov, V. V., Pavlov, I. A., Mashtalir, N., Nadler, J. L., & Drel, V. R. (2007) · Diabetes · doi:10.2337/db06-1176 · Cited by 262
The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy
Singleton, J. R., Bixby, B., Russell, J. W., Feldman, E. L., Peltier, A., Goldstein, J., Howard, J., & Smith, A. G. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00180.x · Cited by 229
Self-citationHyperlipidemia: a new therapeutic target for diabetic neuropathy
Vincent, A. M., Hinder, L. M., Pop‐Busui, R., & Feldman, E. L. (2009) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2009.00237.x · Cited by 178
A controlled investigation of the cause of chronic idiopathic axonal polyneuropathy
Hughes, R. A. C. (2004) · Brain · doi:10.1093/brain/awh192 · Cited by 178
Diabetic neuropathy: one disease or two?
Callaghan, B. C., Hur, J., & Feldman, E. L. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328357a797 · Cited by 161
Hur, J., Sullivan, K. A., Pande, M., Hong, Y., Sima, A. A. F., Jagadish, H. V., Kretzler, M., & Feldman, E. L. (2011) · Brain · doi:10.1093/brain/awr228 · Cited by 158
Oltman, C. L., Coppey, L. J., Gellett, J. S., Davidson, E. P., Lund, D. D., & Yorek, M. A. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00594.2004 · Cited by 131
Azad, N., Emanuele, N., Abraira, C., Henderson, W. G., Colwell, J. A., Levin, S. R., Nuttall, F. Q., Comstock, J. P., Sawin, C. T., Silbert, C. K., et al. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(99)00062-8 · Cited by 130
Idiopathic neuropathy patients are at high risk for metabolic syndrome
Smith, A. G., Rose, K., & Singleton, J. R. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.06.005 · Cited by 123
Self-citationChallenges in Design of Multicenter Trials
Dyck, P. J. B., Norell, J. E., Tritschler, H., Schütte, K., Самигуллин, Р. Р., Ziegler, D., Bastyr, E. J., Litchy, W. J., & O’Brien, P. C. (2007) · Diabetes Care · doi:10.2337/dc06-2479 · Cited by 114
Diet‐induced obesity in Sprague–Dawley rats causes microvascular and neural dysfunction
Davidson, E. P., Coppey, L. J., Calcutt, N. A., Oltman, C. L., & Yorek, M. A. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1088 · Cited by 93
Triglycerides and Amputation Risk in Patients With Diabetes
Callaghan, B. C., Feldman, E. L., Liu, J. Y., Kerber, K. A., Pop‐Busui, R., Moffet, H. H., & Karter, A. J. (2011) · Diabetes Care · doi:10.2337/dc10-0878 · Cited by 75
Prevalence of somatic small fiber neuropathy in obesity
Herman, R. M., Brower, J. B., Stoddard, D. G., Casano, A. R., Targovnik, J. H., Herman, J., & Tearse, P. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803418 · Cited by 74
Cited by
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism
Eid, S., Sas, K. M., Abcouwer, S. F., Feldman, E. L., Gardner, T. W., Pennathur, S., & Fort, P. E. (2019) · Diabetologia · doi:10.1007/s00125-019-4959-1 · Cited by 468
Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease
Horton, W. B., & Barrett, E. J. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa025 · Cited by 424
The importance of weight management in type 2 diabetes mellitus
Wilding, J. P. H. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12384 · Cited by 314
The epidemiology and risk factors of chronic polyneuropathy
Hanewinckel, R., van Oijen, M., Ikram, M. A., & van Doorn, P. A. (2016) · European Journal of Epidemiology · doi:10.1007/s10654-015-0094-6 · Cited by 293
Peripheral neuropathy in prediabetes and the metabolic syndrome
Stino, A. M., & Smith, A. G. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12650 · Cited by 268
Self-citation
Metadata
- Authors
- Smith, A. G., & Singleton, J. R.
- Venue
- Journal of Diabetes and its Complications
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 27
- Issue
- 5
- Pages
- 436-442
- ISSN
- 0891-6632 (ISSN-L)
- 1056-8727
- OpenAlex
- W2118286510
- Cited by
- 272
- References
- 30
- FWCI
- 10.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.